Insulin resistance and metabolic syndrome;Insulinresistenz und metabolisches syndrom

Zeitschrift fur Kardiologie

Volumn 89, Issue 5, 2000, Pages 377-382

  Joost, H G ^a   Giesen, K ^a   Kluge, R ^a   Ortlepp, J ^a   Plum, L ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Diabetes; Hypertension; Insulin resistance; Obesity

Indexed keywords

INSULIN;

DISEASE PREDISPOSITION; DYSLIPOPROTEINEMIA; GENETIC PREDISPOSITION; HYPERTENSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034044875     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050501     Document Type: Review

References (30)

1. Abe H, Yamada N, Kamata K, Kuwaki T, Shimada M, Osuga J, Shionoiri F, Yahagi N, Kadowaki T, Tamemoto H, Ishibashi S, Yazaki Y, Makuuchi M (1998) Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101:1784-1788
2. Brüning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-572
3. Cleland SJ, Petrie JR, Ueda S, Elliott HL, Connell JM (1998) Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease. Clin Exp Pharmacol Physiol 25:175-184
4. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401
5. Collins VR, Dowse GK, Toelupe PM, Imo TT, Aloaina FL, Spark RA, Zimmet PZ (1994) Increasing prevalence of NIDDM in the Pacific island population of Western Samoa over a 13-year period. Diabetes Care 17:288-296
6. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
7. Friedman JM (1997) The alphabet of weight control. Nature 385:119-120
8. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC (1996) Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 93:6231-6235
9. Gunn TM, Miller KA, He L, Hyman RW, Davis RW, Azarani A, Schlossman SF, Duke-Dohan JS, Barsh GS (1999) The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 398:152-156
10. Hamann A, Busing B, Kausch C, Ertl J, Preibisch G, Greten H, Matthaei S (1997) Chronic leptin treatment does not prevent the development of obesity in transgenic mice with brown fat deficiency. Diabetologia 40:810-815
11. Herberg L, Coleman DL (1977) Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26:59-98
12. Igel M, Becker W, Herberg L, Joost HG (1996) Evidence that reduced leptin levels, but not an aberrant sequence of leptin or its receptor, contribute to the obesity syndrome in NON mice. Hormone Metab Res 28:669-674
13. Igel M, Becker W, Herberg L, Joost HG (1997) Hyperleptinemia, leptin resistance and polymorphic leptin receptor in the New Zealand Obese (NZO) mouse. Endocrinology 138:4234-4239
14. Igel M, Taylor BA, Phillips SJ, Becker W, Herberg L, Joost HG (1998) Hyperleptinemia and leptin receptor variant Asp600Asn in the obese, hyperinsulinemic KK mouse strain. J Mol Endocrinol 21:337-345
15. Kahn BB (1998) Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance. Cell 92:593-596
16. Kesaniemi YA, Lilja M, Kervinen K, Rantala A (1992) Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics. Ann Med 24:461-464
17. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635
18. Leibel RL, Chung WK, Chua SC Jr (1997) The molecular genetics of rodent single gene obesities. J Biol Chem 272:1937-1940
19. Leibel RL, Hirsch J (1984) Diminished energy requirements in reduced-obese patients. Metabolism 33:164-170
20. Leiter EH, Herberg L (1997) The polygenetics of diabesity in mice. Diabetes Rev 5:131-148
21. Leiter EH, Reifsnyder PC, Flurkey K, Partke HJ, Junger E, Herberg L (1998) NIDDM genes in mice. Deleterious synergism by both parental genomes contributes to diabetic thresholds. Diabetes 47:1287-1295
22. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG (1999) Obesity induced hypertension: new concepts from the emerging biology of obesity. Hypertension 33:537-541
23. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Barley AR, Barnett AH, Prins JB, O'Rahilly S (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908
24. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138
25. Perusse L, Chagnon YC, Weisnagel J, Bouchard C (1999) The human obesity gene map: the 1998 update. Obes Res 7:111-129
26. Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz LO (1994) Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 17:1067-1074
27. Scherrer U, Sartori C (1997) Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 96:4104-4113
28. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179
29. Wendorf M, Goldfine ID (1991) Archaeology of NIDDM. Excavation of the "thrifty" genotype. Diabetes 40:161-165
30. Zhang Y, Proenca R, Maffei M, Barone M, Leipols L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432